SAN DIEGO, CA (March 24, 2023) – Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — announced that Shawn Levy, Element CSO and SVP of Applications, will give a keynote presentation at the Revolutionizing Next Generation Sequencing Conference taking place March 27-28 in Ghent, Belgium.
A year after launching the AVITI System, Element has continued to innovate on its modular platform, including faster run times, expanded kit offerings, the Elembio Cloud software platform, and industry-leading low costs, all while maintaining unprecedented accuracy. Shawn Levy will address these and other topics in his presentation “Avidity Sequencing on the AVITI System - Sequencing Reimagined” on March 28.
A world-renowned pioneer in genomics research, Dr. Levy has over 20 years of experience in genomic applications development and technology optimization, along with operational management of research, development, and clinical testing programs.
“Element brings new innovations to the market to revolutionize sequencing and enable more discovery,” he said. “We are proud to empower scientists around the world with higher data quality and lower costs so they can reach the next breakthroughs.”
With the establishment of a European entity and a growing sales and support organization, Element can now support a wide variety of applications and research labs. “AVITI’s flexibility, data quality, ease of use, and excellent support team are reasons why the AVITI is quickly turning into the preferred sequencer of choice for workflows that require a mid-throughput sequencer,” said Ewoud Ouwerkerk, General Manager, Europe, at Element.
About Element Biosciences, Inc.
Element Biosciences is a multi-disciplinary life science company currently focused on developing disruptive DNA sequencing technology for research and diagnostic markets. Through innovating every fundamental element of a sequencing system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries and broaden the use of genomic medicine. To learn more about Element, please visit www.elementbiosciences.com.